Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture

Bioactives of Artemisia dracunculus L. (termed PMI 5011) have been shown to improve insulin action by increasing insulin signalling in skeletal muscle. However, it was not known if PMI 5011's effects are retained during an inflammatory condition. We examined the attenuation of insulin action and whether PMI 5011 enhances insulin signalling in the inflammatory environment with elevated cytokines.

[1]  S. Salinari,et al.  Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance , 2013, PloS one.

[2]  D. Ribnicky,et al.  An Extract of Artemisia dracunculus L. Inhibits Ubiquitin-Proteasome Activity and Preserves Skeletal Muscle Mass in a Murine Model of Diabetes , 2013, PloS one.

[3]  M. White,et al.  Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 , 2012, Diabetologia.

[4]  D. Ribnicky,et al.  Proteomic analysis reveals cellular pathways regulating carbohydrate metabolism that are modulated in primary human skeletal muscle culture due to treatment with bioactives from Artemisia dracunculus L. , 2012, Journal of proteomics.

[5]  A. Lochner,et al.  Early cardiovascular changes occurring in diet-induced, obese insulin-resistant rats , 2012, Molecular and Cellular Biochemistry.

[6]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[7]  D. Ribnicky,et al.  Bioactives of Artemisia dracunculus L. Mitigate the Role of Ceramides in Attenuating Insulin Signaling in Rat Skeletal Muscle Cells , 2012, Diabetes.

[8]  M. Serio,et al.  Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. , 2012, European journal of cell biology.

[9]  F. Vannberg,et al.  A Common Haplotype of the TNF Receptor 2 Gene Modulates Endotoxin Tolerance , 2011, The Journal of Immunology.

[10]  P. Pacher,et al.  Evaluation of PMI-5011, an ethanolic extract of Artemisia dracunculus L., on peripheral neuropathy in streptozotocin-diabetic mice. , 2011, International journal of molecular medicine.

[11]  I. Kratchmarova,et al.  Quantitative analysis of the secretion of the MCP family of chemokines by muscle cells. , 2011, Molecular bioSystems.

[12]  D. Ribnicky,et al.  Regulation of insulin action by an extract of Artemisia dracunculus L. in primary human skeletal muscle culture: A proteomics approach , 2010, Phytotherapy research : PTR.

[13]  A. Klip,et al.  Muscle insulin resistance: assault by lipids, cytokines and local macrophages , 2010, Current opinion in clinical nutrition and metabolic care.

[14]  S. Watkins,et al.  A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats. , 2010, American journal of physiology. Endocrinology and metabolism.

[15]  F. Greenway,et al.  Obesity Increases the Production of Proinflammatory Mediators from Adipose Tissue T Cells and Compromises TCR Repertoire Diversity: Implications for Systemic Inflammation and Insulin Resistance , 2010, The Journal of Immunology.

[16]  M. Kanzaki,et al.  Characterization of contraction-inducible CXC chemokines and their roles in C2C12 myocytes. , 2009, American journal of physiology. Endocrinology and metabolism.

[17]  A. Klip,et al.  Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells , 2009, Archives of physiology and biochemistry.

[18]  J. Bastard,et al.  The role of interleukins in insulin resistance and type 2 diabetes mellitus , 2009, Nature Reviews Endocrinology.

[19]  C. Peterson,et al.  Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. , 2009, American journal of physiology. Endocrinology and metabolism.

[20]  I. Raskin,et al.  Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L. , 2009, International journal of pharmaceutics.

[21]  S. Bhattacharya,et al.  Lipid induced overexpression of NF-kappaB in skeletal muscle cells is linked to insulin resistance. , 2009, Biochimica et biophysica acta.

[22]  J. Olefsky,et al.  Insulin sensitivity: modulation by nutrients and inflammation. , 2008, The Journal of clinical investigation.

[23]  I. Raskin,et al.  Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture. , 2008, Metabolism: clinical and experimental.

[24]  I. Raskin,et al.  A natural history of botanical therapeutics. , 2008, Metabolism: clinical and experimental.

[25]  J. Eckel,et al.  Skeletal muscle insulin resistance induced by adipocyte-conditioned medium: underlying mechanisms and reversibility. , 2008, American journal of physiology. Endocrinology and metabolism.

[26]  C. Alviano,et al.  Screening of chemical composition, antimicrobial and antioxidant activities of Artemisia essential oils. , 2008, Phytochemistry.

[27]  I. Raskin,et al.  Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line. , 2007, American journal of physiology. Endocrinology and metabolism.

[28]  L. Boscá,et al.  TLR4-Mediated Survival of Macrophages Is MyD88 Dependent and Requires TNF-α Autocrine Signalling1 , 2007, The Journal of Immunology.

[29]  J. Eckel,et al.  The adipocyte–myocyte axis in insulin resistance , 2006, Trends in Endocrinology & Metabolism.

[30]  I. Raskin,et al.  Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[31]  J. Eckel,et al.  Pathways leading to muscle insulin resistance – The muscle – fat connection , 2006, Archives of physiology and biochemistry.

[32]  H. Ginsberg,et al.  Whole-body insulin resistance in the absence of obesity in FVB mice with overexpression of Dgat1 in adipose tissue. , 2005, Diabetes.

[33]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[34]  M. Dalakas,et al.  Expression of IFN-γ-inducible chemokines in inclusion body myositis , 2003, Journal of Neuroimmunology.

[35]  P. Poulsen,et al.  The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. , 2002, Diabetes.

[36]  A. Israël,et al.  I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .

[37]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[38]  R. Henry,et al.  Insulin Action and Glucose Metabolism in Nondiabetic Control and NIDDM Subjects: Comparison Using Human Skeletal Muscle Cell Cultures , 1995, Diabetes.

[39]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[40]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[41]  I. Raskin,et al.  An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice. , 2011, The Journal of nutritional biochemistry.

[42]  A. Klip,et al.  Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells. , 2009, American journal of physiology. Endocrinology and metabolism.

[43]  A. Saltiel,et al.  Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. , 2007, American journal of physiology. Endocrinology and metabolism.

[44]  L. Boscá,et al.  TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-alpha autocrine signalling. , 2007, Journal of immunology.

[45]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[46]  A. Israël,et al.  I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. , 1997, The EMBO journal.

[47]  D. Baltimore,et al.  NF-kappa B: ten years after. , 1996, Cell.

[48]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.